Advanced therapies address the unmet need in neurology


Merz is deeply committed to offering novel therapeutic options that address the largely unmet medical needs that exist within the area of neuroscience.

Neurological diseases present unique scientific, social, and personal challenges.

Globally, Merz specializes in the research and development of drugs for the treatment of neurological and psychiatric diseases. Merz is a leader in the field of Alzheimer disease research, developing the world’s first drug for the treatment of moderate to severe stages of Alzheimer disease. In addition to Alzheimer research, Merz concentrates on research in fields that have a strong need for therapeutic innovation.

We at Merz understand and are committed to addressing the complexities of treating and living with neurological disorders.

Merz Neuroscience products include: